Document is current
Any future updates will be listed below
-
Authors
Haibe-Kains, Benjamin https://orcid.org/0000-0002-7684-0079
Adam, George Alexandru
Hosny, Ahmed
Khodakarami, Farnoosh
,
Shraddha, Thakkar
Kusko, Rebecca
Sansone, Susanna-Assunta
Tong, Weida
Wolfinger, Russ D.
Mason, Christopher E.
Jones, Wendell
Dopazo, Joaquin
Furlanello, Cesare
Waldron, Levi
Wang, Bo
McIntosh, Chris
Goldenberg, Anna
Kundaje, Anshul https://orcid.org/0000-0003-3084-2287
Greene, Casey S. https://orcid.org/0000-0001-8713-9213
Broderick, Tamara
Hoffman, Michael M. https://orcid.org/0000-0002-4517-1562
Leek, Jeffrey T.
Korthauer, Keegan
Huber, Wolfgang https://orcid.org/0000-0002-0474-2218
Brazma, Alvis https://orcid.org/0000-0001-5988-7409
Pineau, Joelle https://orcid.org/0000-0003-0747-7250
Tibshirani, Robert
Hastie, Trevor
Ioannidis, John P. A.
Quackenbush, John https://orcid.org/0000-0002-2702-5879
Aerts, Hugo J. W. L.
- License Information
-
More Information
Article History
Received: 1 February 2020
Accepted: 10 August 2020
First Online: 14 October 2020
Competing interests
: A.H. is a shareholder of and receives consulting fees from Altis Labs. M.M.H. received a GPU Grant from Nvidia. H.J.W.L.A. is a shareholder of and receives consulting fees from Onc.AI. B.H.K. is a scientific advisor for Altis Labs. C.M. holds an equity position in Bridge7Oncology and receives royalties from RaySearch Laboratories. A.K. is on the SAB of ImmuneAI Inc, a consultant for Biogen Inc., a scientific co-founder of RavelBio Inc. and a shareholder of Freenome Inc. G.A.A., F.K., L.W., B.W., C.S.G., J.T.L., W.H., A.B., J.P., R.T., T.H., J.P.A.I. and J.Q. declare no other competing interests related to the manuscript.
